Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Expansion Device Helps Prepare Children for Ocular Prosthesis

By HospiMedica International staff writers
Posted on 20 Apr 2010
An orbital tissue expander (OTE) facilitates the normal growth of orbital soft tissue and bone, helping to achieve facial symmetry in congenital anophthalmia and microphthalmia.

The integrated OTE is intended for use in infants with congenital anophthalmia, congenital microphthalmia, and acquired anophthalmia due to early ocular tumors or trauma. More...
The system consists of a flexible combined balloon and expander device held in place by a titanium fixation plate, anchored to the lateral orbital wall by titanium screws. A slotted arm attached to the fixation plate extends through a slot that is formed within the OTE. The OTE is thus self-centered in the expanding orbital socket, maintaining its position as the orbit grows. There are two adjustments that are required periodically: inflation of the globe to stimulate bone growth, and confirmation of self-centering. The infant is carefully followed by the surgeon who decides the adjustment intervals required to facilitate the desired result of facial symmetry. The recommended use for the OTE is one year, but optimal removal time is at the surgeon's discretion.

Benefits of the OTE device are implantation using normal oculoplastic surgical techniques, with no further multiple surgeries required. Multiple fixation areas on the bone plate allow for changing fixation points to adjust to the child's growth pattern. The device can easily be inflated or deflated without surgery, as controlled by the doctor, and can also easily be removed and replaced. Inflation of the device is controlled using a 30-gauge disposable hypodermic needle connected to a 1 cc disposable syringe filled with sterile saline, that is inserted into the OTE through an injection port; the inflation effects pressure on the orbit of the patient, expanding it. The integrated OTE is a product of Innovia (Miami, FL, USA).

Anophthalmia and microphthalmia can occur as a secondary result of arrested development of the eye at various stages of growth of the optic vesicle. Anophthalmia, or anophthalmos, is the congenital absence of one or both eyes. Development of the orbital region, as well as the lids and fornices, is dependent upon the presence of a normal-sized eye in utero.

Related Links:

Innovia




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.